Page 43 - JSOM Fall 2023
P. 43

effects with ketamine (hallucinations and altered thoughts and   TABLE 3  Use of Intranasal Analgesia Among the 256* Responding
              feelings). More than half (n = 25; 53.1%) of our sample stated   Physicians
              that additional analgesics were needed despite INA and were            Yes     No     Total
              delivered intravenously by 92% (n = 23) of the respondents.  Variable  (%)**  (%)**   (%)**  p-value
                                                                 Years of practice
              INA was significantly associated with physicians who received   <5 years   13   73     86
              additional training in emergency medicine (p < .001), worked           (5.1)  (28.5)  (33.6)
              shifts on regular basis (p < .001), or supported highly opera-  >5 years   34   136    170    NS
              tional units (p < .01) (Table 3).                                     (13.3)  (53.1)  (66.4)
                                                                 Additional training in emergency medicine
              Respondents were overwhelmingly interested in following a   No          8      89      97
              training course on INA (n = 235; 90.7%) and using this tech-           (3.1)  (34.8)  (37.9)
              nique in France and during deployments (n = 218; 84.1%).  Yes          39      120     159   <.001
                                                                                    (15.2)  (46.9)  (62.1)
              Almost half of the physicians (n = 129; 49.8%) felt that nurses   Emergency medicine shifts on a regular basis
              could be trained to administer IN with an additional 70 (27%)   No     12      95      107
              placing it into the skill set of the combat medic. Only a few          (4.7)  (37.1)  (41.8)
              (n = 19, 7.3%) felt that the use of IN should be stricter to   Yes     35      114     149   .0139
              physician use only.                                                   (13.7)  (44.5)  (58.2)
                                                                 If yes, how often?
              Discussion                                         0–4/month           26      99      125
                                                                                    (10.1)  (38.7)  (48.8)
              The nasal mucosa is a highly vascularized exchange surface   >5/month   9       1      24     NS
              estimated at 120–150cm².  Factors such as a severely deviated          (3.5)   (5.8)   (9.3)
                                  5
              nasal septum, vasoconstrictors, or intranasal hemorrhage can   Number of deployments
                                     6
              reduce its exchange function.   The IN route requires high-
                                                                                             185
                                                                                     37
                                                                                                     222
              quality medication spraying with good distribution over the   1–5 times  (14.4)  (72.3)  (86.7)
              entire nasal mucosa, while avoiding exceedingly large drop-  >5 times   10     24      34     .094
              lets or overall volume. In addition, the mucous membrane ab-           (3.9)   (9.4)  (13.3)
              sorption threshold corresponds to approximately 0.5mL per   Units
                   5
              nostril.  A specific nasal spray is already available (Mucosal
                                                                                                     92
                                                                                             66
                                                                                     26
              Atomization Device, https://www.teleflex.com/usa/en/product   Highly operational****  (10.1)  (25.8)  (35.9)  .0038
              -areas/anesthesia/atomization/mad-nasal-device/index.html).   Regular   21     143     164
              Adapted for use with a syringe, this device provides a fine mist       (8.2)  (55.8)   (64)
              of particles, 30–100 microns in size, and a better medication   *Three surveys were incomplete on the “Use of intranasal analgesia”
              bioavailability.  The efficacy and onset of action of the INA   section.
                         7
              depends on the nasal mucosa absorption, which is in turn de-  **With respect to the number of responses in the sample (256).
              termined  by  the  size  of  the  droplets  (device- dependent),  the   ***>2-month duration
              medication pH, and the liposoluble nature of the medication.   ****Including: Special Forces, Paratroopers, Air Force air ambulance,
              Ketamine*, sufentanil, and fentanyl are rapid and effective   Air Force heliborne search and rescue, Navy medical bay, mountain
                                                                 troops, Paris and Marseille Fire Brigades, and Civil Security.
              IN analgesics with no significant adverse effects and are com-
              monly used in civilian settings (Table 4). 8–20
                                                                 TABLE 4  Main Characteristics of Ketamine, Sufentanil, and
                                                                 Fentanyl 8–20
              The November 2020 TCCC updates recommended the use of
              100µg fentanyl and 50–100mg ketamine for INA in military   Characteristics  Ketamine  Sufentanil  Fentanyl
                         21
              environments.  When this study was performed, no French   Bioavailability  ≈ 40%   ≈ 80%    ≈ 90%
              scientific committee had published recommendations regard-  Intranasal dose  0.5–0.75mg/kg  0.4–0.7µg/kg  1.5µg/kg
              ing  intranasal  analgesia.  Sufentanil,  fentanyl,  and  ketamine               (titration)*
              were off-label for this route of administration.   Onset of action            <10 min**
                                                                 Duration of action   30–60 min** (dose-related)
              The majority of the responding physicians reported being   Most common   Psychodysleptia***  Hypotension and/or
              familiar with INA, although few had a perfect score on the   side effects         respiratory depression
              knowledge MCQs. Most of the respondents expressed an in-  *Loading dose of 0.3µg/kg, then 0.15µg/kg at 10 then 20 minutes (if
              terest in taking a specific INA training course. Training with   the Numerical Rating Scale >3)
              standardized protocols should be implemented as part of in-  **No significant difference
                                                                 ***Psychodysleptia: hallucinations and altered thoughts and feelings
              ternship training or prior to deployment as part of the current
                                22
              French TCCC  training. Continuing professional education
              should also be offered. More than half of our study group had   a small proportion of our surveyed physicians had practical
              a degree in emergency medicine. This qualification is funda-  experience with INA. As expected, those assigned to highly
              mental for military physicians. It gives them an indispensable   operational units mastered INA and had used it significantly
              level of autonomy in remote setting deployments, as the evacu-  more than their counterparts.
              ation time to the nearest forward surgical team can sometimes
                          3
              be 6–12 hours.  Practicing emergency medicine on a regular   Ketamine was the most frequently used medication, as mono-
              basis is essential for improving one’s knowledge in INA. Only   therapy or in association with midazolam. It is a common
                                                                             Intranasal Analgesia in French Armed Forces  |  41
   38   39   40   41   42   43   44   45   46   47   48